Dr. Charles Phan, M.D

NPI: 1457303737
Total Payments
$220,102
2024 Payments
$11,148
Companies
28
Transactions
495
Medicare Patients
1,502
Medicare Billing
$139,432

Payment Breakdown by Category

Other$161,115 (73.2%)
Consulting$23,400 (10.6%)
Travel$22,322 (10.1%)
Food & Beverage$12,989 (5.9%)
Education$275.81 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $161,115 64 73.2%
Consulting Fee $23,400 6 10.6%
Travel and Lodging $22,322 59 10.1%
Food and Beverage $12,989 349 5.9%
Education $275.81 13 0.1%
Unspecified $0 4 0.0%

Payments by Type

General
$220,102
491 transactions
Ownership
$0
4 transactions

Top Paying Companies

Company Total Records Latest Year
Gilead Sciences, Inc. $212,577 367 $0 (2024)
AbbVie Inc. $3,465 26 $0 (2021)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $2,376 56 $0 (2024)
Allergan Inc. $189.87 4 $0 (2019)
FUJIFILM Healthcare Americas Corporation $167.41 2 $0 (2021)
Phadia US Inc. $156.72 1 $0 (2017)
Medtronic, Inc. $147.54 1 $0 (2022)
INTRA-SANA LABORATORIES $125.04 1 $0 (2021)
INTERCEPT PHARMACEUTICALS, INC. $119.37 7 $0 (2023)
BOSTON SCIENTIFIC CORPORATION $117.06 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $11,148 25 Gilead Sciences, Inc. ($10,989)
2023 $13,473 34 Gilead Sciences, Inc. ($13,277)
2022 $37,548 59 Gilead Sciences, Inc. ($37,198)
2021 $15,982 58 Gilead Sciences, Inc. ($15,465)
2020 $6,873 24 Gilead Sciences, Inc. ($6,772)
2019 $44,537 108 Gilead Sciences, Inc. ($39,685)
2018 $35,271 74 Gilead Sciences, Inc. ($34,374)
2017 $55,271 113 Gilead Sciences Inc ($54,815)

All Payment Transactions

495 individual payment records from CMS Open Payments — Page 1 of 20

Date Company Product Nature Form Amount Type
12/17/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $4.28 General
10/26/2024 Gilead Sciences, Inc. Livdelzi (Drug) Food and Beverage In-kind items and services $148.79 General
Category: INFLAM
10/04/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $17.58 General
Category: Gastroenterology
09/17/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $5.35 General
09/11/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $19.80 General
Category: Gastroenterology
09/04/2024 Gilead Sciences, Inc. Livdelzi (Drug) Food and Beverage In-kind items and services $109.01 General
Category: INFLAM
08/20/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $19.41 General
07/26/2024 Gilead Sciences, Inc. Vemlidy (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,030.00 General
Category: HBV
07/12/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $7.01 General
06/06/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $21.12 General
Category: Gastroenterology
05/02/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $65.15 General
04/24/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $21.19 General
Category: Gastroenterology
04/11/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $14.11 General
04/10/2024 Gilead Sciences, Inc. Vemlidy (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,240.00 General
Category: HBV
03/26/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $18.64 General
03/24/2024 Gilead Sciences, Inc. Vemlidy (Drug) Travel and Lodging In-kind items and services $571.36 General
Category: HBV
03/24/2024 Gilead Sciences, Inc. Vemlidy (Drug) Travel and Lodging In-kind items and services $94.00 General
Category: HBV
03/23/2024 Gilead Sciences, Inc. Vemlidy (Drug) Food and Beverage In-kind items and services $50.00 General
Category: HBV
03/23/2024 Gilead Sciences, Inc. Vemlidy (Drug) Food and Beverage In-kind items and services $31.50 General
Category: HBV
03/23/2024 Gilead Sciences, Inc. Vemlidy (Drug) Food and Beverage In-kind items and services $30.00 General
Category: HBV
03/01/2024 Gilead Sciences, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,030.00 General
02/23/2024 Gilead Sciences, Inc. Vemlidy (Drug) Travel and Lodging In-kind items and services $469.21 General
Category: HBV
02/21/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $14.24 General
Category: Gastroenterology
02/15/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $116.15 General
2024 GastroGPO, LLC $0.00 Ownership

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 7 415 469 $159,850 $38,048
2022 7 408 482 $178,792 $36,754
2021 6 291 386 $108,852 $28,607
2020 6 388 519 $155,837 $36,023
Total Patients
1,502
Total Services
1,856
Medicare Billing
$139,432
Procedure Codes
26

All Medicare Procedures & Services

26 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 75 75 $63,525 $10,175 16.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 129 167 $24,716 $9,603 38.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 84 99 $21,483 $8,668 40.3%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 32 32 $10,624 $3,845 36.2%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 41 42 $28,560 $3,114 10.9%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 41 41 $8,979 $2,147 23.9%
99202 New patient office or other outpatient visit, 15-29 minutes Office 2023 13 13 $1,963 $496.08 25.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 135 201 $29,748 $10,961 36.8%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 74 74 $62,678 $8,154 13.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 51 59 $12,803 $4,995 39.0%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 19 19 $20,273 $3,476 17.1%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 49 49 $32,380 $3,427 10.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 30 30 $9,960 $2,934 29.5%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 50 50 $10,950 $2,807 25.6%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 137 229 $33,892 $14,005 41.3%
45380 Biopsy of the large bowel using an endoscope (colonoscopy) Facility 2021 46 47 $39,264 $5,760 14.7%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 57 57 $12,483 $4,036 32.3%
43239 Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope Facility 2021 26 28 $16,408 $2,152 13.1%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 12 12 $3,984 $1,439 36.1%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 13 13 $2,821 $1,216 43.1%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 178 307 $45,436 $15,437 34.0%
45380 Biopsy of large bowel using an endoscope Facility 2020 54 55 $46,585 $6,777 14.5%
99203 New patient office or other outpatient visit, typically 30 minutes Office 2020 82 82 $17,958 $5,564 31.0%
43239 Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope Facility 2020 41 42 $24,612 $3,402 13.8%
45385 Removal of polyps or growths of large bowel using an endoscope Facility 2020 14 14 $14,938 $2,871 19.2%

About Dr. Charles Phan, M.D

Dr. Charles Phan, M.D is a Gastroenterology healthcare provider based in Sugar Land, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457303737.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Phan, M.D has received a total of $220,102 in payments from pharmaceutical and medical device companies, with $11,148 received in 2024. These payments were reported across 495 transactions from 28 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($161,115).

As a Medicare-enrolled provider, Phan has provided services to 1,502 Medicare beneficiaries, totaling 1,856 services with total Medicare billing of $139,432. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Location Sugar Land, TX
  • Active Since 05/16/2006
  • Last Updated 08/05/2015
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • NPI Number 1457303737

Products in Payments

  • Vemlidy (Drug) $134,259
  • Epclusa (Drug) $21,766
  • Vosevi (Drug) $4,278
  • Mavyret (Drug) $3,011
  • XIFAXAN (Drug) $2,226
  • Creon (Drug) $361.09
  • Livdelzi (Drug) $257.80
  • LINZESS (Drug) $189.87
  • uTASWako AFP-L3 (Device) $167.41
  • TRULANCE (Drug) $164.30
  • ImmunoCAP (Device) $156.72
  • INTERSTIM (Device) $147.54
  • RELTONE 200 MG (Drug) $125.04
  • Truvada (Drug) $125.00
  • OCALIVA (Drug) $119.37
  • GENERAL BRADY (Device) $117.06
  • Linzess (Drug) $97.66
  • ZONTIVITY (Drug) $68.72
  • Viekira (Drug) $66.03
  • GATTEX (Drug) $64.62

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Sugar Land